This inventor holds 1 USPTO granted patent. Top assignee: Hyal Pharmaceutical Corporation. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Anita Aviad: Innovator in Hyaluronic Acid Formulations
Introduction
Anita Aviad is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of veterinary medicine through her innovative work on hyaluronic acid formulations. Her research focuses on creating pure, sterile, and pyrogen-free solutions that are essential for intra-articular treatments in animals.
Latest Patents
Anita holds a patent for her invention titled "Pure, sterile, pyrogen-free hyaluronic acid formulations and their methods." This patent describes a heat-stable, purified, and heat-sterilized fraction of hyaluronic acid. It is designed for use in formulations aimed at treating degenerative joint diseases in animals. The formulation includes specific components such as minor amounts of sulphated mucopolysaccharides, chlorides, and preservatives, ensuring its efficacy and safety for veterinary applications.
Career Highlights
Anita Aviad is associated with Hyal Pharmaceutical Corporation, where she continues to develop her innovative formulations. Her work has been instrumental in advancing treatment options for animals suffering from joint-related ailments. With her expertise, she has established herself as a key figure in the field of veterinary pharmaceuticals.
Collaborations
Anita collaborates with her coworker, Alan Drizen, to further enhance the development of hyaluronic acid formulations. Their combined efforts aim to improve the quality and effectiveness of treatments available for animals.
Conclusion
Anita Aviad's contributions to the field of veterinary medicine through her innovative hyaluronic acid formulations highlight her dedication to improving animal health. Her work continues to pave the way for advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile